Your Ad Here
PatientsVille.com> Glucagon Report List> Glucagon Side Effects
If You had Glucagon side effect, You are not alone. Other patients reported side effects.
Do You Have Glucagon Side Effects? Enter Your Symptoms:
Use to quickly submit your side effect
Indicate Your Glucagon Side Effects
Burning Sensation Inside The Body Everywhere (1)
Burning Sensation Inside The Body Everywhere, Seve (1)
Irritability (1)
Severe Nausea (1)
>>See All

Common Glucagon Side Effects

top 5 Glucagon|Burning se|Burning se|Irritabili|Severe nau adverse effects>>See All Glucagon Side Effects

Report Detailed Information

Detailed Reporting will help others get complete information and find alternative treatments to avoid or reduce side effects associated with it.

Ask Glucagon Community

Ask patient community about Glucagon related health issues.

View FDA Reports

Glucagon adverse events reported to FDA.

Have You Experienced unusual Glucagon symptoms? PatientsVille.com collects and analyzes Glucagon side effect and adverse reports submitted by Glucagon users, such as .

Summary

FDA Adverse Reports: 36. View All

Glucagon FDA safety alerts: No

Reported deaths: 1

Reported hospitalizations: 28

Glucagon Dosage, Warnings, Usage.

Post Your Unusual Symptoms:

Most Reported
1Burning Sensation Inside The Body Everywhere, Severe Nausea, Irritability
2Burning Sensation Inside The Body Everywhere
3Severe Nausea
4Irritability
View More
Recent Drug Reports

More Glucagon Side Effect Reports

Questions

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

blog comments powered by Disqus

Often additional risks of using a medication, such as Glucagon, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Glucagon users, Learn more about unwanted side effects & find ways to reduce them. Browse Glucagon Adverse Reports reported to FDA and participate in Glucagon discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Glucagon. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines. Browse More Drug Reports Here: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Search By Drug Names, Symptoms or a Health Condition

Loading

Glucagon Adverse Effect Reports (FDA)

For a quick way to Report Unusual Symptoms, Enter here:

6927653-8 | Anaphylactic Reaction
on Aug 06, 2010 Male patient from JAPAN , child 8 years of age, weighting 46.30 lb, was diagnosed with glucagon tolerance test and was treated with Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Glucagon dosage: 0.6 Mg, Qd. Patient was hospitalized.

6913719-5 | Blood Pressure Decreased, Nausea, Pallor, Somnolence
Patient was taking Glucagon (View Usage). Patient had the following side effects: blood pressure decreased, nausea (What is nausea?), pallor, somnolence on Jul 30, 2010 from JAPAN Additional patient health information: Male patient , child 8 years of age, weighting 46.30 lb, was diagnosed with glucagon tolerance test and. Glucagon dosage: 0.6 Mg, Qd. Patient was hospitalized.

6913366-5 | Blood Pressure Decreased, Cold Sweat, Feeling Abnormal
Adverse event was reported on Jul 20, 2010 by a Male patient taking Glucagon (View Usage) (Dosage: 1 Mg, Single) was diagnosed with hypertension, nuclear magnetic resonance imaging, anaemia, gastritis and. Location: JAPAN , 44 years of age, After Glucagon was administered, patient had the following side effects: blood pressure decreased, cold sweat, feeling abnormal. During the same period patient was treated with AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), PROHANCE (/iv) (View Prohance Review and Prohance Label ), FERROMIA /00023516/ (5 Mg, Qd) (View Ferromia /00023516/ Review and Ferromia /00023516/ Label ), MUCOSTA (10 Mg, Qd) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6879590-5 | Blood Pressure Decreased, Cold Sweat, Feeling Abnormal
on Jul 20, 2010 Male patient from JAPAN , 44 years of age, was diagnosed with hypertension, nuclear magnetic resonance imaging, anaemia, gastritis and was treated with Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cold sweat, feeling abnormal. Glucagon dosage: 1 Mg, Single. During the same period patient was treated with AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), PROHANCE (/iv) (View Prohance Review and Prohance Label ), FERROMIA /00023516/ (5 Mg, Qd) (View Ferromia /00023516/ Review and Ferromia /00023516/ Label ), MUCOSTA (10 Mg, Qd) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.


6847498-7 | Shock Hypoglycaemic
on Jul 07, 2010 Female patient from JAPAN , 44 years of age, was diagnosed with hypertension, nuclear magnetic resonance imaging, anaemia, gastritis and was treated with Glucagon (View Usage). Patient had the following side effects: shock hypoglycaemic. Glucagon dosage: 1 Mg, Single. During the same period patient was treated with AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), PROHANCE (/iv) (View Prohance Review and Prohance Label ), FERROMIA /00023516/ (5 Mg, Qd) (View Ferromia /00023516/ Review and Ferromia /00023516/ Label ), MUCOSTA (10 Mg, Qd) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6516230-9 | Hypoglycaemia, Lactic Acidosis
Patient was taking Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: hypoglycaemia, lactic acidosis on Dec 17, 2009 from JAPAN Additional patient health information: Male patient , weighting 13.23 lb, was diagnosed with glucagon tolerance test and. Glucagon dosage: 0.2 Mg, Qd. Patient was hospitalized.

6504983-5 | Hypoglycaemia, Lactic Acidosis
Adverse event was reported on Dec 07, 2009 by a Male patient taking Glucagon (View Usage) (Dosage: 0.2 Mg, Qd) was diagnosed with glucagon tolerance test and. Location: JAPAN , weighting 13.23 lb, Patient experienced the following unwanted or unexpected effects: hypoglycaemia, lactic acidosis. Patient was hospitalized.

5941430-6 | Injection Site Extravasation
on Nov 03, 2008 Male patient from UNITED STATES , 48 years of age, weighting 154.3 lb, was diagnosed with gastrointestinal obstruction and was treated with Glucagon (View Usage). Patient had the following side effects: injection site extravasation. Glucagon dosage: 1mg Once Iv.

5927692-X | Shock
on Oct 17, 2008 Male patient from JAPAN , 65 years of age, weighting 172.0 lb, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: shock. Glucagon dosage: 1 Mg, Single. Patient was hospitalized.

5922483-8 | Shock
Patient was taking Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: shock on Oct 08, 2008 from JAPAN Additional patient health information: Male patient , 65 years of age, weighting 172.0 lb, was diagnosed with colonoscopy (What is colonoscopy?) and. Glucagon dosage: 1 Mg, Single. Patient was hospitalized.

5383138-4 | Hypoglycaemic Seizure
Adverse event was reported on Jul 02, 2007 by a Male patient taking Glucagon (View Usage) (Dosage: Unk, As Needed) was diagnosed with diabetes mellitus and. Location: UNITED STATES , child 12 years of age, Patient had the following side effects: hypoglycaemic seizure. Patient was hospitalized.

5370154-1 | Device Malfunction, Hypoglycaemic Seizure
on Jun 18, 2007 Male patient from UNITED STATES , child 12 years of age, was diagnosed with diabetes mellitus and was treated with Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: device malfunction, hypoglycaemic seizure. Glucagon dosage: Unk, As Needed. Patient was hospitalized.

5337801-1 | Dizziness, Hyperhidrosis, Hypotension, Nausea, Syncope
on May 16, 2007 Female patient from JAPAN , 80 years of age, weighting 121.3 lb, was diagnosed with endoscopy gastrointestinal, hyperlipidaemia, gastritis, neurogenic bladder, constipation (What is constipation?) and was treated with Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hyperhidrosis, hypotension, nausea (What is nausea?), syncope. Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with PRAVASTATIN (5 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), ITOPRIDE HYDROCHLORIDE (50 Mg, Qd) (View Itopride Hydrochloride Review and Itopride Hydrochloride Label ), DISTIGMINE BROMIDE (5 Mg, Qd) (View Distigmine Bromide Review and Distigmine Bromide Label ), PANTETHINE (2 Mg, Qd) (View Pantethine Review and Pantethine Label ), MAGNESIUM OXIDE (2 G, Qd) (View Magnesium Oxide Review and Magnesium Oxide Label ), SENNOSIDE /00571901/ (24 Mg, Qd) (View Sennoside /00571901/ Review and Sennoside /00571901/ Label ), PHOSCHOL (1500 Mg, Qd) (View Phoschol Review and Phoschol Label ). Patient was hospitalized.

5336594-1 | Dizziness, Hyperhidrosis, Hypotension, Nausea, Syncope
Patient was taking Glucagon (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hyperhidrosis, hypotension, nausea (What is nausea?), syncope on May 16, 2007 from JAPAN Additional patient health information: Female patient , 80 years of age, weighting 121.3 lb, was diagnosed with endoscopy gastrointestinal, hyperlipidaemia, gastritis, neurogenic bladder, constipation (What is constipation?) and. Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with PRAVASTATIN (5 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), ITOPRIDE HYDROCHLORIDE (50 Mg, Qd) (View Itopride Hydrochloride Review and Itopride Hydrochloride Label ), DISTIGMINE BROMIDE (5 Mg, Qd) (View Distigmine Bromide Review and Distigmine Bromide Label ), PANTETHINE (2 Mg, Qd) (View Pantethine Review and Pantethine Label ), MAGNESIUM OXIDE (2 G, Qd) (View Magnesium Oxide Review and Magnesium Oxide Label ), SENNOSIDE /00571901/ (24 Mg, Qd) (View Sennoside /00571901/ Review and Sennoside /00571901/ Label ), PHOSCHOL (1500 Mg, Qd) (View Phoschol Review and Phoschol Label ). Patient was hospitalized.

5329716-X | Dizziness, Hypotension, Pulse Abnormal
Adverse event was reported on May 09, 2007 by a Male patient taking Glucagon (View Usage) (Dosage: 1 Mg, Unk) was diagnosed with gastritis, benign prostatic hyperplasia and. Location: JAPAN , 69 years of age, After Glucagon was administered, patient had the following side effects: dizziness (What is dizziness?), hypotension, pulse abnormal. During the same period patient was treated with SOLON (View Solon Review and Solon Label ), PERAPRIN (View Peraprin Review and Peraprin Label ), FLIVAS (View Flivas Review and Flivas Label ), LENDORMIN (View Lendormin Review and Lendormin Label ). Patient was hospitalized.

5328421-3 | Dizziness, Hyperhidrosis, Nausea, Syncope
on May 07, 2007 Female patient from JAPAN , 80 years of age, weighting 121.3 lb, was diagnosed with endoscopy gastrointestinal, hyperlipidaemia, gastritis, neurogenic bladder, constipation (What is constipation?) and was treated with Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?), syncope. Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with PRAVASTATIN (5 Mg, Qd) (View Pravastatin Review and Pravastatin Label ), ITOPRIDE HYDROCHLORIDE (50 Mg, Qd) (View Itopride Hydrochloride Review and Itopride Hydrochloride Label ), DISTIGMINE BROMIDE (5 Mg, Qd) (View Distigmine Bromide Review and Distigmine Bromide Label ), PANTETHINE (2 Mg, Qd) (View Pantethine Review and Pantethine Label ), MAGNESIUM OXIDE (2 G, Qd) (View Magnesium Oxide Review and Magnesium Oxide Label ), SENNOSIDE /00571901/ (24 Mg, Qd) (View Sennoside /00571901/ Review and Sennoside /00571901/ Label ). Patient was hospitalized.

5292016-0 | Jaw Fracture, Loss Of Consciousness
on Mar 28, 2007 Male patient from JAPAN , 55 years of age, was diagnosed with endoscopy upper gastrointestinal tract and was treated with Glucagon (View Usage). Patient had the following side effects: jaw fracture, loss of consciousness. Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with GASCON (2 Ml, Unk) (View Gascon Review and Gascon Label ), PRONASE MS (20000 Ut, Unk) (View Pronase Ms Review and Pronase Ms Label ), XYLOCAINE /00033402/ (10 Ml, Unk) (View Xylocaine /00033402/ Review and Xylocaine /00033402/ Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ). Patient was hospitalized.

5239286-2 | Blood Glucose Decreased, Bradycardia, Hypotension, Loss Of Consciousness
Patient was taking Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: blood glucose decreased, bradycardia, hypotension, loss of consciousness on Feb 05, 2007 from JAPAN Additional patient health information: Male patient , 75 years of age, weighting 136.7 lb, . Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ). Patient was hospitalized.

5237351-7 | Hypotension
Adverse event was reported on Feb 01, 2007 by a Male patient taking Glucagon (View Usage) (Dosage: ) was diagnosed with endoscopy upper gastrointestinal tract and. Location: JAPAN , 51 years of age, Patient experienced the following unwanted or unexpected effects: hypotension. During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), ITOROL (View Itorol Review and Itorol Label ), GASTER D (View Gaster D Review and Gaster D Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ).

5227441-7 | Hypotension
on Jan 30, 2007 Male patient from JAPAN , 51 years of age, was diagnosed with endoscopy upper gastrointestinal tract and was treated with Glucagon (View Usage). Patient had the following side effects: hypotension. Glucagon dosage: . During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), ITOROL (View Itorol Review and Itorol Label ), GASTER D (View Gaster D Review and Gaster D Label ).

5224857-X | Blood Glucose Decreased, Bradycardia, Hypotension, Loss Of Consciousness
on Jan 18, 2007 Male patient from JAPAN , 75 years of age, was treated with Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: blood glucose decreased, bradycardia, hypotension, loss of consciousness. Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ). Patient was hospitalized.

5215941-5 | Blood Glucose Decreased, Bradycardia, Hypotension, Loss Of Consciousness
Patient was taking Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, bradycardia, hypotension, loss of consciousness on Jan 12, 2007 from JAPAN Additional patient health information: Male patient , 75 years of age, . Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ). Patient was hospitalized.

5190883-2 | Fall, Loss Of Consciousness
Adverse event was reported on Dec 13, 2006 by a Male patient taking Glucagon (View Usage) (Dosage: ) was diagnosed with endoscopy upper gastrointestinal tract and. Location: JAPAN , 51 years of age, Patient had the following side effects: fall (What is fall?), loss of consciousness. During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), GASTER D (View Gaster D Review and Gaster D Label ).

5148833-0 | Blood Glucose Decreased, Loss Of Consciousness
on Oct 30, 2006 Male patient from JAPAN , 75 years of age, was treated with Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: blood glucose decreased, loss of consciousness. Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ). Patient was hospitalized.

5148707-5 | Blood Glucose Decreased, Bradycardia, Hypertension, Loss Of Consciousness
on Oct 30, 2006 Male patient from JAPAN , 75 years of age, was treated with Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, bradycardia, hypertension, loss of consciousness. Glucagon dosage: 1 Mg, Unk. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ). Patient was hospitalized.

5142462-0 | Blood Glucose Decreased
Patient was taking Glucagon (View Usage). Patient had the following side effects: blood glucose decreased on Oct 25, 2006 from CANADA Additional patient health information: Female patient , 62 years of age, . Glucagon dosage: . Patient was hospitalized.

5117440-8 | Decreased Appetite, Neoplasm Malignant
Adverse event was reported on Sep 08, 2006 by a Female patient taking Glucagon (View Usage) (Dosage: ) was diagnosed with blood glucose decreased and. Location: UNITED STATES , 30 years of age, After Glucagon was administered, patient had the following side effects: decreased appetite, neoplasm malignant.

5064870-9 | Cardio-respiratory Arrest, Depressed Level Of Consciousness, Disseminated Intravascular Coagulation, Haemodialysis, Hypoglycaemia, Ischaemic Hepatitis, Renal Failure Acute, Rhabdomyolysis
on Jun 12, 2006 Male patient from JAPAN , 68 years of age, was diagnosed with nausea (What is nausea?) and was treated with Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, depressed level of consciousness, disseminated intravascular coagulation, haemodialysis, hypoglycaemia, ischaemic hepatitis, renal failure acute, rhabdomyolysis. Glucagon dosage: . During the same period patient was treated with GASTER D (40 Mg, Unk) (View Gaster D Review and Gaster D Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.

5045840-3 | Cardio-respiratory Arrest, Depressed Level Of Consciousness, Disseminated Intravascular Coagulation, Haemodialysis, Hypoglycaemia, Ischaemic Hepatitis, Renal Failure, Respiratory Failure, Rhabdomyolysis
on Jun 12, 2006 Male patient from JAPAN , 68 years of age, was diagnosed with nausea (What is nausea?) and was treated with Glucagon (View Usage). Patient had the following side effects: cardio-respiratory arrest, depressed level of consciousness, disseminated intravascular coagulation, haemodialysis, hypoglycaemia, ischaemic hepatitis, renal failure, respiratory failure, rhabdomyolysis. Glucagon dosage: . During the same period patient was treated with GASTER D (40 Mg, Unk) (View Gaster D Review and Gaster D Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized and became disabled.

5040437-3 | Cardio-respiratory Arrest, Depressed Level Of Consciousness, Disseminated Intravascular Coagulation, Hypoglycaemia, Ischaemic Hepatitis, Renal Failure, Respiratory Failure, Rhabdomyolysis
Patient was taking Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: cardio-respiratory arrest, depressed level of consciousness, disseminated intravascular coagulation, hypoglycaemia, ischaemic hepatitis, renal failure, respiratory failure, rhabdomyolysis on Jun 12, 2006 from JAPAN Additional patient health information: Male patient , 68 years of age, was diagnosed with nausea (What is nausea?) and. Glucagon dosage: . During the same period patient was treated with GASTER D (40 Mg, Unk) (View Gaster D Review and Gaster D Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized and became disabled.

4987406-7 | Medical Device Complication
Adverse event was reported on Apr 27, 2006 by a Male patient taking Glucagon (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , child 9 years of age, weighting 72.00 lb, Patient experienced the following unwanted or unexpected effects: medical device complication.

4803174-3 | Cheilitis, Eczema, Epidermal Necrosis, Glucagonoma, Necrolytic Migratory Erythema
on Sep 27, 2005 Female patient from UNITED STATES , 38 years of age, was diagnosed with hypoglycaemia and was treated with Glucagon (View Usage). Patient had the following side effects: cheilitis, eczema (What is eczema?), epidermal necrosis, glucagonoma, necrolytic migratory erythema. Glucagon dosage: .

4803162-7 | Axillary Vein Thrombosis, Embolism, Glucagonoma, Jugular Vein Thrombosis, Oedema Peripheral, Pain In Extremity, Subclavian Vein Thrombosis, Thrombophlebitis, Venous Thrombosis
on Sep 27, 2005 Male patient from UNITED STATES , 57 years of age, was diagnosed with hypoglycaemia and was treated with Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: axillary vein thrombosis, embolism, glucagonoma, jugular vein thrombosis, oedema peripheral, pain in extremity, subclavian vein thrombosis, thrombophlebitis, venous thrombosis. Glucagon dosage: 1.1 Mg Hour. Patient was hospitalized.

4665291-0 | Blood Glucose Decreased, Coma
Patient was taking Glucagon (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, coma on May 02, 2005 from Additional patient health information: Female patient , 59 years of age, was diagnosed with hypoglycaemia and. Glucagon dosage: .

4648984-0 | Cardio-respiratory Arrest, Hypoglycaemia, Myocardial Infarction, Sick Sinus Syndrome, Ventricular Dysfunction
Adverse event was reported on Apr 08, 2005 by a Female patient taking Glucagon (View Usage) (Dosage: ) was diagnosed with hypoglycaemia and. Location: , 59 years of age, weighting 130.1 lb, Patient had the following side effects: cardio-respiratory arrest, hypoglycaemia, myocardial infarction, sick sinus syndrome, ventricular dysfunction. During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), COLACE (DOCUSATE SODIUM) (View Colace (docusate Sodium) Review and Colace (docusate Sodium) Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PRILOSEC (OMEPRAZOLE RATIOPHARM) (View Prilosec (omeprazole Ratiopharm) Review and Prilosec (omeprazole Ratiopharm) Label ), GLUCOSAMIDE SULFATE (View Glucosamide Sulfate Review and Glucosamide Sulfate Label ), IMITREX (View Imitrex Review and Imitrex Label ). Patient was hospitalized.

4626040-5 | Blood Glucose Increased, Blood Potassium Increased, Blood Pressure Decreased, Cerebrovascular Accident, Coma, Convulsion, Diabetes Mellitus, Hallucination, Hip Arthroplasty
on Mar 10, 2005 Female patient from , 62 years of age, weighting 92.59 lb, was treated with Glucagon (View Usage). After Glucagon was administered, patient had the following side effects: blood glucose increased, blood potassium increased, blood pressure decreased, cerebrovascular accident, coma, convulsion, diabetes mellitus, hallucination, hip arthroplasty. Glucagon dosage: . During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), IMURAN (View Imuran Review and Imuran Label ), PROGRAF (View Prograf Review and Prograf Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FLORINEF (GLUDROCORTISONE ACETATE) (View Florinef (gludrocortisone Acetate) Review and Florinef (gludrocortisone Acetate) Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), AMITRIPTYLINE HCL TAB (View Amitriptyline Hcl Tab Review and Amitriptyline Hcl Tab Label ). Patient was hospitalized.


Share Your Experience, Join the Discussion:

Go to the top of the page

Glucagon Questions, Answers, Feedback and Comments

No comments have been provided.

To find out about documented side effects or safety concerns read either the drug label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. All medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety alerts, adverse reports. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Be aware of the following potential Glucagon risks to be aware of: 1. Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
2. Any potential Glucagon quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
3. Potential Glucagon use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
4. When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

Go to the top of the page
Go to the top of the page

Mobile version
How Did You Deal with Side Effects?

About Glucagon : Risks and Benefits, News and Updates, Glucagon video and TV resources

Post Dextrose Side Effect Reporting Your Dextrose side effect will help others recognize and deal with Dextrose side effects. Recent Reports View Dextrose reports ...

Severe hypoglycemia requiring the assistance of another person and/or parenteral glucose infusion or glucagon administration has been observed in clinical trials with ...

Which Hormones in these list do which things: ACTH, Androgens, ADH, Calcitonin, Epinephrine, Glucagon, Glucocorticoids, Insulin, Oxytocin, PTH, Thyroxine Break down ...

Report a Drug Side Effect. ... This anonymous Drug Side Effect Survey has 13 questions and takes less than 2 minutes to complete.

A. secretes cortisol into the blood B. secretes epinephrine C. secretes the hormones insulin and glucagon into the blood D. does none of the above The rate at which we ...

and describe the feedback mechanisms that control their release a insulin---glucagon b parathyroid hormone---calcitonin c thyrotropin (THS)---thyroxine (T4) 2.

During the same period patient was treated with HORIZON (View Horizon Review and Horizon Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), URSO 250 (View Urso 250 ...

During the same period patient was treated with GLUCAGON (1 Mg Once Iv) (View Glucagon Review and Glucagon Label ). 6885316-1 | Product Solubility Abnormal, Product ...

> Medical Devices

> Side Effects Wiki

Follow Us on Twitter

Glucagon Reactions
Anaphylactic Reaction
Axillary Vein Thrombosis
Blood Glucose Decreased
Blood Glucose Increased
Blood Potassium Increased
Blood Pressure Decreased
Bradycardia
Cardio-respiratory Arrest
Cerebrovascular Accident
Cold Sweat
Coma
Depressed Level Of Consciousness
Disseminated Intravascular Coagulation
DizzinessWhat is Dizziness?
Feeling Abnormal
Glucagonoma
Haemodialysis
Hyperhidrosis
Hypoglycaemia
Hypoglycaemic Seizure
Hypotension
Ischaemic Hepatitis
Lactic Acidosis
Loss Of Consciousness
NauseaWhat is Nausea?
Renal Failure
Respiratory Failure
Rhabdomyolysis
Shock
Syncope
Glucagon Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Glucagon adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!